psilocin

News

Entropy, UCSF Pre-CTA for Ph2 psilocin vs Lexapro in MDD

Entropy signs Pre-CTA with UCSF to develop a US-based Phase 2 trial comparing IV psilocin treatment directly against escitalopram (Lexapro) in MDD.

News

Consolidation in psychedelics starts as Beckley and Eleusis ...

Psychedelic medicines company Beckley Psytech has reached an agreement to acquire its rival Eleusis Therapeutics, in alignment with predictions that the sector is heading for a period of co

News

An older woman with rheumatoid arthritis holds her wrist in pain while sat in an armchair

Spyre deprioritises arthritis drug after Phase 2 results

Spyre Therapeutics’ hopes for its anti-TL1A antibody SPY072 in rheumatoid arthritis (RA) have hit a bump in the road.

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Editor's Picks